Stem Cells
Therapies
Stem Cells Therapies
The purpose of banking stem cells is to apply them in the therapy. For the first time cord blood was used in 1988 and since then according to publicly available statistics it has been used over 85 000 times worldwide (including statistics of China).
FamiCord Group stores over 1,000,000 samples of cells of different types and has supplied stem cells for application in clinic for more than 7000 patients. We supply stem cells for standard transplantations (cord blood , bone marrow and mobilized peripheral blood) and cellular therapies. On top of that we provide cell based products in GMP standard for clinical trials.
Stem cells manufactured in our premises helped patients with various diseases and therapeutic areas, including haematological, neurological, ophthalmological, orthopaedical, dermatological disorders.
Check the full list of patients who received stem cell therapy derived from FamiCord labs.
List last update: 06.2026
List of patients who received stem cells from FamiCord Group laboratories
| Lp. | Source | Source type | Diagnosis | Medical field | Year of application | Therapy | Country | Age of recipient |
|---|---|---|---|---|---|---|---|---|
| 6501 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 54 |
| 6502 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 72 |
| 6503 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 54 |
| 6504 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 58 |
| 6505 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 63 |
| 6506 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 48 |
| 6507 | Apheresis | Autologous | Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 62 |
| 6508 | Apheresis | Allogeneic | Non-Hodgkin Lymphoma; Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 6509 | Apheresis | Autologous | Non-Hodgkin-Lymphoma-Relapse | Hematology | 2018 | Standard Therapy | Germany | 51 |
| 6510 | Apheresis | Allogeneic | Other Malignancy | Hematology | 2018 | Standard Therapy | Poland | 59 |
| 6511 | Apheresis | Allogeneic | Other Myelodysplastic Syndromes | Hematology | 2018 | Standard Therapy | Poland | 67 |
| 6512 | Apheresis | Allogeneic | Other Myelofibrosis | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 6513 | Apheresis | Allogeneic | Peripheral T-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Poland | 50 |
| 6514 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2018 | Standard Therapy | Poland | 64 |
| 6515 | Apheresis | Allogeneic | Plasma Cell Disorder | Hematology | 2018 | Standard Therapy | Poland | 57 |
| 6516 | Apheresis | Autologous | Plasma Cell Leukemia | Hematology | 2018 | Standard Therapy | Germany | 52 |
| 6517 | Apheresis | Allogeneic | Post-Essential Thrombocythemia-Myelofibrosis | Hematology | 2018 | Standard Therapy | Germany | 53 |
| 6518 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 6519 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 69 |
| 6520 | Apheresis | Autologous | Primary Central Nervous System Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 66 |
| 6521 | Apheresis | Autologous | Primary Central Nervous System Lymphoma Relapse | Hematology | 2018 | Standard Therapy | Germany | 63 |
| 6522 | Apheresis | Allogeneic | Primary Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 3 |
| 6523 | Apheresis | Allogeneic | Primary Myelofibrosis; Secondary Acute Myelogenous Leukemia | Hematology | 2018 | Standard Therapy | Poland | 53 |
| 6524 | Apheresis | Allogeneic | Prolymphocytic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 62 |
| 6525 | Apheresis | Autologous | Refractory Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 36 |
| 6526 | Apheresis | Allogeneic | Refractory Diffuse Large B-Cell Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 50 |
| 6527 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Poland | 58 |
| 6528 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia | Hematology | 2018 | Standard Therapy | Germany | 68 |
| 6529 | Apheresis | Allogeneic | Secondary Acute Myeloid Leukemia At Primary Myelofibrosis | Hematology | 2018 | Standard Therapy | Germany | 56 |
| 6530 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 18 |
| 6531 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 74 |
| 6532 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 24 |
| 6533 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 70 |
| 6534 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 6 |
| 6535 | Apheresis | Allogeneic | Severe Aplastic Anemia | Hematology | 2018 | Standard Therapy | Poland | 13 |
| 6536 | Apheresis | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2018 | Standard Therapy | Poland | 2 |
| 6537 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 7 |
| 6538 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 13 |
| 6539 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 45 |
| 6540 | Apheresis | Allogeneic | T-Cell Acute Lymphoblastic Leukemia | Hematology | 2018 | Standard Therapy | Poland | 40 |
| 6541 | Apheresis | Autologous | T-Cell Non-Hodgkin Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 6542 | Apheresis | Autologous | T-Cell-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 67 |
| 6543 | Apheresis | Allogeneic | T-Cell-Lymphoma | Hematology | 2018 | Standard Therapy | Germany | 23 |
| 6544 | Apheresis | Allogeneic | Thalassemia Major | Hematology | 2018 | Standard Therapy | Poland | 5 |
| 6545 | Apheresis | Allogeneic | Therapy-Related Myelodysplastic Syndromes | Hematology | 2018 | Standard Therapy | Poland | 65 |
| 6546 | Adipose Tissue | Autologous | Condition After Injury Of The Left Knee Joint | Orthopedy | 2018 | Experimental Therapy | Poland | 33 |
| 6547 | Adipose Tissue | Autologous | Coxarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 53 |
| 6548 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6549 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6550 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6551 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6552 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6553 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6554 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6555 | Adipose Tissue | Autologous | Cutis Laxa | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6556 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 69 |
| 6557 | Adipose Tissue | Autologous | Gonarthrosis | Orthopedy | 2018 | Experimental Therapy | Poland | 42 |
| 6558 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6559 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6560 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6561 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6562 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6563 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6564 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6565 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6566 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6567 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6568 | Adipose Tissue | Autologous | Scar | Dermatology | 2018 | Clinical Trial | Poland | 0 |
| 6569 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 44 |
| 6570 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 25 |
| 6571 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 38 |
| 6572 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 26 |
| 6573 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 37 |
| 6574 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 62 |
| 6575 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 35 |
| 6576 | Cord Tissue | Allogeneic – Unrelated | Limb-Girdle Muscular Dystrophy | Neurology | 2017 | Experimental Therapy | Poland | 31 |
| 6577 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 13 |
| 6578 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 11 |
| 6579 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 2 |
| 6580 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 8 |
| 6581 | Cord Tissue | Allogeneic – Unrelated | Acute Graft Versus Host Disease | Hematology | 2017 | Experimental Therapy | Poland | 7 |
| 6582 | Cord Tissue | Allogeneic – Unrelated | Age-Related Macular Degeneration | Ophthalmology | 2017 | Experimental Therapy | Poland | 33 |
| 6583 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 67 |
| 6584 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 37 |
| 6585 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 71 |
| 6586 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 0 |
| 6587 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 47 |
| 6588 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 56 |
| 6589 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 48 |
| 6590 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 46 |
| 6591 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 45 |
| 6592 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 75 |
| 6593 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 51 |
| 6594 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 59 |
| 6595 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 64 |
| 6596 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 56 |
| 6597 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 40 |
| 6598 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 69 |
| 6599 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 52 |
| 6600 | Cord Tissue | Allogeneic – Unrelated | Amyotrophic Lateral Sclerosis | Neurology | 2017 | Experimental Therapy | Poland | 35 |